rs2143918

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_017436.7(A4GALT):​c.-188+2783T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.424 in 152,098 control chromosomes in the GnomAD database, including 15,424 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.42 ( 15424 hom., cov: 33)

Consequence

A4GALT
NM_017436.7 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.05

Publications

9 publications found
Variant links:
Genes affected
A4GALT (HGNC:18149): (alpha 1,4-galactosyltransferase (P1PK blood group)) The protein encoded by this gene catalyzes the transfer of galactose to lactosylceramide to form globotriaosylceramide, which has been identified as the P(k) antigen of the P blood group system. This protein, a type II membrane protein found in the Golgi, is also required for the synthesis of the bacterial verotoxins receptor. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2015]
CYB5R3 (HGNC:2873): (cytochrome b5 reductase 3) This gene encodes cytochrome b5 reductase, which includes a membrane-bound form in somatic cells (anchored in the endoplasmic reticulum, mitochondrial and other membranes) and a soluble form in erythrocytes. The membrane-bound form exists mainly on the cytoplasmic side of the endoplasmic reticulum and functions in desaturation and elongation of fatty acids, in cholesterol biosynthesis, and in drug metabolism. The erythrocyte form is located in a soluble fraction of circulating erythrocytes and is involved in methemoglobin reduction. The membrane-bound form has both membrane-binding and catalytic domains, while the soluble form has only the catalytic domain. Alternate splicing results in multiple transcript variants. Mutations in this gene cause methemoglobinemias. [provided by RefSeq, Jan 2010]
CYB5R3 Gene-Disease associations (from GenCC):
  • methemoglobinemia
    Inheritance: AR Classification: DEFINITIVE Submitted by: Illumina
  • methemoglobinemia due to deficiency of methemoglobin reductase
    Inheritance: AR Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • hereditary methemoglobinemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.802 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
A4GALTNM_017436.7 linkc.-188+2783T>G intron_variant Intron 1 of 2 ENST00000642412.2 NP_059132.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
A4GALTENST00000642412.2 linkc.-188+2783T>G intron_variant Intron 1 of 2 NM_017436.7 ENSP00000494127.1

Frequencies

GnomAD3 genomes
AF:
0.424
AC:
64436
AN:
151980
Hom.:
15429
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.205
Gnomad AMI
AF:
0.416
Gnomad AMR
AF:
0.463
Gnomad ASJ
AF:
0.496
Gnomad EAS
AF:
0.823
Gnomad SAS
AF:
0.554
Gnomad FIN
AF:
0.527
Gnomad MID
AF:
0.525
Gnomad NFE
AF:
0.488
Gnomad OTH
AF:
0.457
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.424
AC:
64443
AN:
152098
Hom.:
15424
Cov.:
33
AF XY:
0.431
AC XY:
32051
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.205
AC:
8491
AN:
41484
American (AMR)
AF:
0.463
AC:
7064
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.496
AC:
1720
AN:
3468
East Asian (EAS)
AF:
0.822
AC:
4258
AN:
5178
South Asian (SAS)
AF:
0.553
AC:
2671
AN:
4826
European-Finnish (FIN)
AF:
0.527
AC:
5577
AN:
10580
Middle Eastern (MID)
AF:
0.531
AC:
156
AN:
294
European-Non Finnish (NFE)
AF:
0.488
AC:
33153
AN:
67984
Other (OTH)
AF:
0.461
AC:
974
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1786
3573
5359
7146
8932
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
604
1208
1812
2416
3020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.448
Hom.:
3629
Bravo
AF:
0.408
Asia WGS
AF:
0.612
AC:
2128
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
8.6
DANN
Benign
0.72
PhyloP100
1.0

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2143918; hg19: chr22-43114020; API